INGN vs MRNA · rev $180.2M vs rev $145.0M
Inogen Inc (INGN) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Inogen Inc (INGN) is a medical devices company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported INGN revenue for 2026-06-30 was $180.2M. Net income was -$12.2M. INGN currently screens at market cap $173.5M.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
INGN currently screens at market cap $173.5M. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the INGN and MRNA stock pages for the full models.
Not investment advice.